NCT06810739Recruiting
The Women's Screening and Self-Testing Program (PROMETA) Study
A Hybrid Type III Effectiveness - Implementation, Pragmatic Intervention Trial for Cervical Cancer Screen and Treat in Mozambique
Source: ClinicalTrials.gov · Last updated 20 Jul 2026
Brief summary (registry, in English)
This proposal directly addresses the ability to safely scale-up a Screen-Triage-Treat approach to cervical cancer screening. The investigators propose to capitalize on a pool of screen-eligible women accessing routine care within targeted human immunodeficiency virus (HIV) care and treatment services. The primary outcome of interest is the number of women screened and the proportion of screen-positive women undergoing treatment. Secondary outcomes will focus on other implementation outcomes, and if successful, will be utilized to inform future research to take this approach to scale across Mozambique.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 8445 (estimated)
- First submitted
- 28 Jan 2025
- Start date
- 13 Jul 2026
- Primary completion date
- 30 Jun 2028
- Lead sponsor
- Tulane University
- Diseases
- HIV, Cervical cancer
- NCT number
- NCT06810739
What you commit to
- Study type: Interventional
- Planned participants: 8445
- From 13 Jul 2026 to the primary completion date, 30 Jun 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Physical or mental impairment that inhibits participation in the study
Other
- Pregnant women or \<6 weeks post-partum
- Women who have undergone a total hysterectomy with removal of the cervix
Who the study is looking for
- Women 25-49 years
- Accessing HIV care and treatment services
- Not being pregnant
- Patients with a cervix
Age in the registry: 25 years to 49 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Eduardo Mondlane (UEM) Coordinator of this site? Confirm its status | Maputo | Mozambique | Recruiting |
Related publications
- A hybrid type III effectiveness-implementation study designed to test implementation best practices of deploying a Screen-Triage-Treat approach to cervical cancer screening and management utilizing self-collected HPV DNA testing in Chokwe District, Mozambique.BMC Public Health · 2025 · PMID 41291606
This page is information, not medical advice. Discuss any trial with your doctor.